BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2011
View Archived Issues
Nicotinic acetylcholine alpha5 receptor may represent new target of smoking cessation therapies
Read More
FDA grants accelerated approval to Hologic's Makena to reduce risk of preterm delivery
Read More
Snapshots: Recent clinical trials of briakinumab in psoriasis
Read More
Apremilast reduces severity of psoriasis and improves quality of life
Read More
Galapagos receives IWT grant for antiviral drug discovery
Read More
Merck & Co. reviews operations of fourth quarter 2010
Read More
TEAM trial compares exemestane alone to sequential tamoxifen/exemestane therapy in breast cancer
Read More
Algenpantucel-L plus adjuvant therapy improves survival of patients with resected pancreatic cancer
Read More
Combination of 90Y-hPAM4 and gemcitabine shows promise in advanced pancreatic cancer
Read More
TC-5214 enters phase IIb trial in major depressive disorder
Read More
Depomed reports phase I data on DM-1992 in Parkinson's disease
Read More
Helix BioPharma clear to conduct phase I L-DOS-47 trial in U.S.
Read More
Progenics and Salix Pharma enter into license agreement for Relistor
Read More
Harbor BioSciences completes phase I/IIa Apoptone trial in prostate cancer
Read More
Cell culture model mimics breast ductal system for design of nanoparticle therapies and diagnostics
Read More
Optimer Pharma and Astellas enter agreement for antibiotic fidaxomicin
Read More
Phosphagenics enters agreement to develop TPM-delivered antipsoriasis drug
Read More
Pharmaxis' Bronchitol approved in Australia for cystic fibrosis
Read More
NMS describes in silico model to predict myelosuppressive activity of drugs
Read More
Third phase III Avastin trial in ovarian cancer meets primary endpoint
Read More
FDA approves labeling update to Reyataz for HIV-infected pregnant women
Read More
Ansaris earns milestone payment from Ono Pharma with identification of kinase-related agent
Read More
Lundbeck is granted rights to several Cephalon products in Canada and Latin America
Read More
GSK adds new safety information and restrictions on use to rosiglitazone-containing medicines
Read More